Energy stocks drive gains in European shares

Reuters

Warning: This material has been prepared by a third party company, Reuters, which is independent of Davy. Davy has not reviewed the material and accepts no responsibility for errors or omissions, or for the information or opinions contained therein. It does not constitute investment advice.

 (For a live blog on European stocks, type LIVE/ in an Eikon
news window)
    Dec 4 (Reuters) - European shares rose on Friday, with
energy stocks lifting London's blue-chip index to nine-month
highs, while BioNtech slid after Pfizer slashed the roll-out
target of their COVID-19 vaccine.
    London FTSE 100 rose 0.5% as energy stocks gained after a
compromise between OPEC+ members to continue some production
cuts.  O/R   MET/L   IRONORE/ 
    The pan-European STOXX 600 index  .STOXX  was up 0.2%, while
Germany's DAX  .GDAXI  underperformed and was trading flat.
    Shares of Germany's BioNtech  22UAy.F  slid 4.4% after
Pfizer  PFE.N  said supply chain obstacles forced it to slash
the 2020 production target of its COVID-19 vaccine developed
with BioNtech by half.  urn:newsml:reuters.com:*:nL1N2IJ309
    Meanwhile, data showed German industrial orders rose more
than expected on the month in October, raising hopes the
manufacturing sector in Europe's biggest economy started the
fourth quarter on a solid footing.  urn:newsml:reuters.com:*:nL8N2IK0ZR

 (Reporting by Susan Mathew in Bengaluru; Editing by Shounak
Dasgupta)
 ((susan.mathew@thomsonreuters.com; +91-80-6287-2704))

Warning: This content may be provided by regulated and unregulated entities and is not created, reviewed or endorsed by Davy. It is provided for general information purposes only and does not constitute a recommendation or solicitation to purchase or sell any security or make any other type of investment or investment decision. Importantly, it does not constitute investment advice, as it does not contemplate the personal circumstances of any particular person or group of persons. Neither Davy nor the providers of the Third Party Content will be liable for any investment decision made based on the reliance on or use of such data, or any liability that may arise due to delays or interruptions in the delivery of the Third Party Content for any reason.